About
- - Company
    - About Sensus Healthcare
    - Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions.
      
      Read More
  - Patient Advocates
  - FAQ
    - - What is SRT?
        We offer a painless, safe and highly effective non-surgical skin cancer treatment that is an alternative to surgery—Superficial Radiation Therapy using the SRT-100™.
        
        Go to FAQ
      - What does SRT treat?
        The SRT-100™ is an excellent treatment option for patients with the following conditions: Keloid scars, Basal cell carcinoma, Squamous cell carcinoma, Metatypical carcinoma, Cutaneous appendage carcinoma, Actinic keratosis, Kaposi’s sarcoma.
        
        Go to FAQ
      - Is SRT right for me?
        The SRT-100™ doesn’t harm surrounding or underlying healthy tissue while targeting cancer cells. The SRT-100™ provides excellent cosmetic outcomes and is a great alternative for patients with various co-morbidities.
        
        Go to FAQ
      - What should I expect?
        You should expect the same results as surgery, but with these additional benefits: No pain, No anesthesia, No cutting, No bleeding, No stitching, No scarring, No interruption of lifestyle, No reconstructive surgery
        
        Go to FAQ
      - Is the SRT-100 safe?
        The SRT-100™ is a safe and proven technology that effectively treats non-melanoma skin cancers, keloid scarring, actinic keratosis and Kaposi’s sarcoma. It is utilized by dermatologists and radiation oncologists all over the world because it delivers good patient outcomes.
        
        Go to FAQ
  - Careers
    - - Sensus - Field Service Engineer
    - View Career Opportunities
Physicians
Patients
Investors
- Corporate Governance Guidelines
- Code of Ethics and Business Conduct
Resources
Contact Us

Zoom Meeting Recording: Skin Cancer Awareness Month & Treatment During COVID-19

Thank you to all of those who attended our second Zoom meeting discussing Skin Cancer Awareness month and treating patients during COVID-19. Our CEO, founder, and chairman Joe Sardano was joined by Dr. Ellen Turner, MD of Dermatology of Dallas and Dr. Kristine Romine, MD, FAAD, PCEO of Camelback Dermatology and Skin Surgery.

The topics that were discussed during the meeting included:

How COVID-19 has impacted treatment and doctor/patient relations
The decline in skin cancer inquiries while the public focuses on COVID
Skin Cancer Awareness Month: Bringing focus back to skin cancer for a wary public
The ability to still treat patients with SRT during this time
Aesthetic/Elective surgeries vs skin cancer treatment
Telehealth for skin cancer checks
COVID-19 changing the way certain things are done within the practice & moving forward